MDxHealth (MDXH) Income from Non-Controlling Interests (2021 - 2023)
MDxHealth (MDXH) posted Income from Non-Controlling Interests of -$587.3 million for Q3 2022, down 381.89% sequentially from -$121.9 million in Q3 2021, and down 381.89% YoY from $208.3 million in Q3 2021.
MDxHealth (MDXH) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends
MDxHealth has reported Income from Non-Controlling Interests for 2 years, with the latest figure at -$587.3 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 14.00 Mn |
| 10 | MDxHealth | 21.82 Mn | -21.33 Mn | 16.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -486,000.00 |
| Mar 31, 2023 | 287,000.00 |
| Sep 30, 2022 | -587.31 Mn |
| Sep 30, 2021 | -121.88 Mn |